Check-Cap Ltd.

NASDAQ:CHEK

1.79 (USD) • At close September 13, 2024
Bedrijfsnaam Check-Cap Ltd.
Symbool CHEK
Munteenheid USD
Prijs 1.79
Beurswaarde 10,472,144
Dividendpercentage 0%
52-weken bereik 1.77 - 4.625
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Alex Ovadia
Website https://www.check-cap.com

An error occurred while fetching data.

Over Check-Cap Ltd.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for

Vergelijkbare Aandelen

Delcath Systems, Inc. logo

Delcath Systems, Inc.

DCTH

9.54 USD

Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc.

CABA

4.11 USD

Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp.

TNXP

0.157 USD

Immunome, Inc. logo

Immunome, Inc.

IMNM

15.97 USD

X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.

XFOR

0.71 USD

Protara Therapeutics, Inc. logo

Protara Therapeutics, Inc.

TARA

1.88 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)